Results 201 to 210 of about 120,862 (212)

Pembrolizumab for triple-negative breast cancer

The Lancet Oncology, 2020
openaire   +2 more sources

Src: a potential target for the treatment of triple-negative breast cancer

Annals of Oncology, 2011
Michael Duffy, A Pierce, E W Mcdermott
exaly  

Survival among women with triple receptor-negative breast cancer and brain metastases

Annals of Oncology, 2009
Shaheenah Dawood, A M Gonzalez-Angulo, F J Esteva   +2 more
exaly  

Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy

Annals of Oncology, 2013
Dajun Deng, L Diao, S A Narod
exaly  

MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition

Journal of Experimental Medicine, 2012
Andrei Goga, , Gordon Mills
exaly  

What is triple-negative breast cancer?

European Journal of Cancer, 2008
Lisa Carey, William J Irvin
exaly  

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

New England Journal of Medicine, 2018
CARLOS Barrios, Sherene Loi, Hope Rugo   +2 more
exaly  

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

Annals of Oncology, 2009
M Clynes
exaly  

Advances in the Systemic Treatment of Triple-Negative Breast Cancer

Current Oncology, 2018
E Powell
exaly  

Triple-negative breast cancer fly

Lab Animal
openaire   +2 more sources